The only pharma intelligence company covering the global market
See the whole picture with PHARMALERT
VISION
Pharmalert monitors regulatory approvals globally
Keeping you up to date on the market reach of your molecules of interest, whether you are a drug developer on the watch for first-mover generics and biosimilars or you want to verify that your biopharma investment targets are capitalizing on the full potential of their products.
We do not rely on companies' press releases. We provide you with comprehensive data on when and where your medicines of interest gain approval or lose market dominance to competitors.
%2011_31_39.png)
Simple subscribing process
HIRING OUR SERVICE
SEARCH YOUR MOLECULE
Go to our SIGN UP page to search through our portfolio by brand name, generic name or developer, or CONTACT US to request unlisted molecules
WHY PHARMALERT
We have a background of 10+ years in the biopharmaceutical sector
And 5+ years’ experience monitoring the developments in the global healthcare industry, including the regulatory process necessary for a drug to enter a market and generate profit.
We know what to look for and we don’t stop watching.
OUR SCOPE AT A GLANCE
Some of the companies we work with
